BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 10997548)

  • 21. Results of initial low-dose computed tomographic screening for lung cancer.
    ; Church TR; Black WC; Aberle DR; Berg CD; Clingan KL; Duan F; Fagerstrom RM; Gareen IF; Gierada DS; Jones GC; Mahon I; Marcus PM; Sicks JD; Jain A; Baum S
    N Engl J Med; 2013 May; 368(21):1980-91. PubMed ID: 23697514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimates of smoking-attributable mortality and hospitalization in BC, 2002-2007.
    Tu AW; Buxton JA; Stockwell T
    Can J Public Health; 2012; 103(2):137-41. PubMed ID: 22530538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Forecasting sex differences in mortality in high income nations: The contribution of smoking.
    Pampel F
    Demogr Res; 2005 Oct; 13(18):455-484. PubMed ID: 21874120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimating the effect of smoking on slowdowns in mortality declines in developed countries.
    Rostron BL; Wilmoth JR
    Demography; 2011 May; 48(2):461-79. PubMed ID: 21519979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity.
    Finkelstein J; Cha E; Scharf SM
    Int J Chron Obstruct Pulmon Dis; 2009; 4():337-49. PubMed ID: 19802349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Smoking-attributable mortality and years of potential life lost in 16 Brazilian capitals, 2003: a prevalence-based study.
    Corrêa PC; Barreto SM; Passos VM
    BMC Public Health; 2009 Jun; 9():206. PubMed ID: 19558658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using the National Health Interview Survey to understand and address the impact of tobacco in the United States: past perspectives and future considerations.
    Backinger CL; Lawrence D; Swan J; Winn DM; Breen N; Hartman A; Grana R; Tran D; Farrell S
    Epidemiol Perspect Innov; 2008 Dec; 5():8. PubMed ID: 19055824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The disease burden attributable to smoking in the state of Rio de Janeiro, Brazil in 2000.
    Oliveira AF; Valente JG; Leite IC
    Clinics (Sao Paulo); 2008 Apr; 63(2):215-22. PubMed ID: 18438576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methodologies used to estimate tobacco-attributable mortality: a review.
    Pérez-Ríos M; Montes A
    BMC Public Health; 2008 Jan; 8():22. PubMed ID: 18211696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mortality, morbidity and costs attributable to smoking in Germany: update and a 10-year comparison.
    Neubauer S; Welte R; Beiche A; Koenig HH; Buesch K; Leidl R
    Tob Control; 2006 Dec; 15(6):464-71. PubMed ID: 17130376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimating health-adjusted life expectancy conditional on risk factors: results for smoking and obesity.
    van Baal PH; Hoogenveen RT; de Wit GA; Boshuizen HC
    Popul Health Metr; 2006 Nov; 4():14. PubMed ID: 17083719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of public policies in reducing smoking prevalence in California: results from the California tobacco policy simulation model.
    Levy DT; Hyland A; Higbee C; Remer L; Compton C
    Health Policy; 2007 Jul; 82(2):167-85. PubMed ID: 17055104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Smoking attributable mortality for Taiwan and its projection to 2020 under different smoking scenarios.
    Wen CP; Tsai SP; Chen CJ; Cheng TY; Tsai MC; Levy DT
    Tob Control; 2005 Jun; 14 Suppl 1(Suppl 1):i76-80. PubMed ID: 15923454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regional, disease specific patterns of smoking-attributable mortality in 2000.
    Ezzati M; Lopez AD
    Tob Control; 2004 Dec; 13(4):388-95. PubMed ID: 15564623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimating smoking-attributable mortality.
    Tanuseputro P; Schultz S; Manuel D
    Can J Public Health; 2004; 95(2):132; author reply 132, 157. PubMed ID: 15074904
    [No Abstract]   [Full Text] [Related]  

  • 36. Respiratory symptoms correlating to smoking prevalence: the National Nutrition Survey and the National Life-style Survey in Japan.
    Asahi S; Uehara R; Watanabe M; Tajimi M; Oki I; Ojima T; Nakamura Y; Oguri S; Okayama A; Matsumura Y; Yanagawa H
    J Epidemiol; 2003 Jul; 13(4):226-31. PubMed ID: 12934966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimating the health consequences of replacing cigarettes with nicotine inhalers.
    Sumner W
    Tob Control; 2003 Jun; 12(2):124-32. PubMed ID: 12773720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Smoking and risk of premature death among middle-aged Japanese: ten-year follow-up of the Japan Public Health Center-based prospective study on cancer and cardiovascular diseases (JPHC Study) cohort I.
    Hara M; Sobue T; Sasaki S; Tsugane S
    Jpn J Cancer Res; 2002 Jan; 93(1):6-14. PubMed ID: 11802802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methodological issues in estimating smoking-attributable mortality in the United States.
    Malarcher AM; Schulman J; Epstein LA; Thun MJ; Mowery P; Pierce B; Escobedo L; Giovino GA
    Am J Epidemiol; 2000 Sep; 152(6):573-84. PubMed ID: 10997548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lung cancer mortality among never-smokers in the United States: estimating smoking-attributable mortality with nationally representative data.
    Lariscy JT; Hummer RA; Rogers RG
    Ann Epidemiol; 2020 May; 45():5-11. PubMed ID: 32439149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.